Solitaire™ With the Intention For Thrombectomy as PRIMary Endovascular Treatment (SWIFT PRIME) Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The primary study objective is to determine if subjects experiencing an acute ischemic stroke due to large vessel occlusion, treated with combined IV t-PA and Solitaire Revascularization Device within 6 hours of symptom onset have less stroke-related neurological disability (mRS) than those subjects treated with IV t-PA alone
Epistemonikos ID: 283072c6ffa3a82e8ee2c2848db5532d774a7c65
First added on: Oct 16, 2018